BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martin-Rendon E, Snowden JA, Watt SM. Stem cell-related therapies for vascular diseases. Transfus Med 2009;19:159-71. [PMID: 19706133 DOI: 10.1111/j.1365-3148.2009.00926.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Badr Eslam R, Croce K, Mangione FM, Musmann R, Leopold JA, Mitchell RN, Waxman AB. Persistence and proliferation of human mesenchymal stromal cells in the right ventricular myocardium after intracoronary injection in a large animal model of pulmonary hypertension. Cytotherapy 2017;19:668-79. [PMID: 28392314 DOI: 10.1016/j.jcyt.2017.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vuorio T, Jauhiainen S, Ylä-herttuala S. Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors. Expert Opinion on Biological Therapy 2011;12:79-92. [DOI: 10.1517/14712598.2012.641011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
3 Jiang D, Qi Y, Walker NG, Sindrilaru A, Hainzl A, Wlaschek M, MacNeil S, Scharffetter-Kochanek K. The effect of adipose tissue derived MSCs delivered by a chemically defined carrier on full-thickness cutaneous wound healing. Biomaterials 2013;34:2501-15. [PMID: 23317813 DOI: 10.1016/j.biomaterials.2012.12.014] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
4 Watt SM, Athanassopoulos A, Harris AL, Tsaknakis G. Human endothelial stem/progenitor cells, angiogenic factors and vascular repair. J R Soc Interface 2010;7 Suppl 6:S731-51. [PMID: 20843839 DOI: 10.1098/rsif.2010.0377.focus] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
5 Walker NG, Mistry AR, Smith LE, Eves PC, Tsaknakis G, Forster S, Watt SM, Macneil S. A chemically defined carrier for the delivery of human mesenchymal stem/stromal cells to skin wounds. Tissue Eng Part C Methods 2012;18:143-55. [PMID: 21943098 DOI: 10.1089/ten.TEC.2011.0037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
6 Brunskill SJ, Hyde CJ, Doree CJ, Watt SM, Martin-Rendon E. Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009;11:887-96. [PMID: 19654139 DOI: 10.1093/eurjhf/hfp101] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
7 Hamdi H, Planat-Benard V, Bel A, Puymirat E, Geha R, Pidial L, Nematalla H, Bellamy V, Bouaziz P, Peyrard S, Casteilla L, Bruneval P, Hagège AA, Agbulut O, Menasché P. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc Res 2011;91:483-91. [PMID: 21565832 DOI: 10.1093/cvr/cvr099] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]